CCM
DMAQR

Context Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Context Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-198,000
Closed -$63K – 760
2021
Q4 		$63K Buy
+198,000
New +$62.6K ﹤0.01% 457

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Context Capital Management's DMAQR Position: Q1 2022 in Review

Context Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2022, closing a stake of 198,000 shares — an estimated $63K sold.

Context Capital Management first reported a position in DMAQR in Q4 2021 and held it in 1 quarter. The position peaked at $63K in Q4 2021. 28 funds tracked by Wall St. Rank hold DMAQR as of Q1 2022.

  • Context Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2022 after selling out during the quarter.
  • Context Capital Management sold 198,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2022, an estimated $63K.
  • Context Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 1 quarter.
  • Context Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $63K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2022.

Based on Context Capital Management's 13F filing for Q1 2022, filed 9 May 2022.